Bioinformatics brings to light new combinations of drugs to fight breast cancer

Bioinformatics brings to light new combinations of drugs to fight breast cancer


Combined therapy using two drugs emerges as a promising approach to tackle cancer resistance. Biocomputational analyses at IRB help to detect new synergistic combinations, such as raloxifene and cabozantinib, for the treatment of breast cancer.



from Biotech News